Ceftriaxone no longer predictably cures chancroid in Kenya.
Date
1993Author
Tyndall, M
Malisa, M
Plummer, FA
Ombetti, J
Ndinya-Achola, JO
Ronald, AR
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Ceftriaxone in a dose of 250 mg given intramuscularly is currently recommended for the treatment of chancroid. Among 133 men in Nairobi, Kenya, with culture-proven chancroid, who were treated with ceftriaxone, treatment failed in 35%. Poor outcome was associated with human immunodeficiency virus type 1 seropositivity. Thus, treatment recommendations for chancroid should be reevaluated.
URI
http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/8421184http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/16985
Citation
J Infect Dis. 1993 Feb;167(2):469-71Publisher
Department of Medicine, University of Manitoba, Winnipeg, Canada.
Collections
- Faculty of Health Sciences (FHS) [10378]